- Home
- Publications
- Publication Search
- Publication Details
Title
Anakinra treatment in patients with gout and type 2 diabetes
Authors
Keywords
Anakinra, Autoinflammatory disorders, Gout, Interleukin (IL)-1β, Type 2 diabetes
Journal
CLINICAL RHEUMATOLOGY
Volume 34, Issue 5, Pages 981-984
Publisher
Springer Nature
Online
2014-04-14
DOI
10.1007/s10067-014-2601-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Revisiting comorbidities in gout: a cluster analysis
- (2013) Pascal Richette et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin-1 antagonists for diabetes
- (2013) Thomas Mandrup-Poulsen EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Treating inflammation by blocking interleukin-1 in humans
- (2013) Charles A. Dinarello et al. SEMINARS IN IMMUNOLOGY
- Efficacy of anakinra in gouty arthritis: a retrospective study of 40 cases
- (2013) Sébastien Ottaviani et al. ARTHRITIS RESEARCH & THERAPY
- Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions
- (2012) Naomi Schlesinger et al. ANNALS OF THE RHEUMATIC DISEASES
- Autoinflammatory syndromes and cellular responses to stress: pathophysiology, diagnosis and new treatment perspectives
- (2012) Sinisa Savic et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: Results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study
- (2012) H. Ralph Schumacher et al. ARTHRITIS CARE & RESEARCH
- Interleukin-1 inhibition by anakinra in refractory chronic tophaceous gout
- (2011) Ai P. TRAN et al. International Journal of Rheumatic Diseases
- Neutralizing Interleukin-1β (IL-1β) Induces β-Cell Survival by Maintaining PDX1 Protein Nuclear Localization
- (2011) Amin Ardestani et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Accelerated Increase in Serum Interleukin-1 Receptor Antagonist Starts 6 Years Before Diagnosis of Type 2 Diabetes: Whitehall II Prospective Cohort Study
- (2010) M. Carstensen et al. DIABETES
- Blocking interleukin-1β in acute and chronic autoinflammatory diseases
- (2010) C. A. Dinarello JOURNAL OF INTERNAL MEDICINE
- The Effect of the Interleukin-1 Cytokine Family Members IL-1F6 and IL-1F8 on Adipocyte Differentiation
- (2010) Edwin J.P. van Asseldonk et al. Obesity
- Horror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory Disease
- (2009) Seth L. Masters et al. Annual Review of Immunology
- Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes
- (2009) C. M. Larsen et al. DIABETES CARE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now